← Leaderboard
EW
Ticker
EW
Congressional Trades
28
by 8 members
Ticker Intelligence Brief
Who in Congress traded EW, when, and what happened after?
A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.
Latest receipt
Ro Khanna
BUY · 2026-05-27
Largest range
$50K – $100K
Jefferson Shreve
Slowest filing
147d
Tommy Tuberville
Best vs SPY
6.1%
Ro Khanna
Buys
13
46%
Sells
15
54%
Total Volume
$383K
midpoint
Unique Traders
8
members
Party Breakdown
Democrats15 · 54%
Republicans13 · 46%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthALIGNEDBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
—
Apr '23
1▲1▼
—
Jun '23
1▲
—
Apr '24
0▲2▼
0▲1▼
Aug '24
—
1▲
Nov '24
—
1▲
Mar '25
1▲
—
Apr '25
2▲2▼
—
May '25
0▲2▼
0▲1▼
Oct '25
—
0▲3▼
Nov '25
—
0▲1▼
Feb '26
—
1▲1▼
Mar '26
—
1▲1▼
Apr '26
—
3▲
May '26
—
Democrats7▲8▼Neutral
vs
Republicans5▲7▼Net sellers
Net buyingNet selling⚡ Party split
🏛️ Federal Contracts
all →- 2026-06-18$65KDepartment of Veterans AffairsPROSTHETICS: TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) SURGICAL IMPLANTS RESTOCK
- 2026-06-18$34KDepartment of Veterans AffairsTAVR HEART VALVES EXERCISE OPTION TWO.
- 2026-06-17$34KDepartment of Veterans AffairsPROS-NONRHEUMATIC AORTIC (VALVE) STENOSIS
- 2026-06-16$34KDepartment of Veterans AffairsS3URCM26A: RESILIA TRANSCATHETER HEART VALVE, 26MM
- 2026-06-15$34KDepartment of Veterans AffairsIMPLANT
- 2026-06-12$34KDepartment of Veterans AffairsTAVR HEART VALVES EXERCISE OPTION TWO.
- 2026-06-12$33KDepartment of Veterans AffairsS3 ULTRA VALVE, 26MM, MODEL #: 9750TFX26A
- 2026-06-12$33KDepartment of Veterans AffairsS3 ULTRA VALVE, 29MM, MODEL #: 9600TFX29A
- 2026-06-11$34KDepartment of Veterans AffairsRESILIA VALVE (TAVR) - BILL ONLY
- 2026-06-11$34KDepartment of Veterans AffairsHEART VALVE
💼 Lobbying Filings
all →- 2026-04-20$340KEDWARDS LIFESCIENCES LLCEnsuring Patient Access to Critical Breakthrough Products (H.R.5343/S.1717) (includes MCIT/TCET) Transitional Coverage for Emerging Technologies (TCET)/MCIT Policies promoting medical innovation Heart Valve Disease Awareness AI in Healthcare FDA Reauthorization/FDA User Fees Diversity in Clinical Trials (Health Equity Issues) Coverage with Evidence Development CMS Coverage Policies For Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R.5343/S.1717) (includes MCIT/TCET) Heart Valve Disease Awareness Transcatheter Mitral Valve National Coverage Decision National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials (Health Equity Issues) Coverage with Evidence Development Tariffs
- 2026-04-20$50KEDWARDS LIFESCIENCES LLCCoverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. Coverage with evidence development. 21st Century Cures 2.0
- 2026-04-20$50KEDWARDS LIFESCIENCES LLCProvide analysis and strategic advocacy support services to Edwards Lifesciences public policy priorities, including FDA regulatory and CMS coverage and reimbursement issue
- 2026-04-20$50KEDWARDS LIFESCIENCES LLCMedicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders; Issues related to Senate Finance Dear Colleague process
- 2026-01-20$350KEDWARDS LIFESCIENCES LLCEnsuring Patient Access to Critical Breakthrough Products (H.R. 5343/S.1717) Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization/FDA User Fees Diversity in Clinical Trials CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R. 5343/S.1717) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development Japan Reimbursement of Medical Devices
- 2026-01-20$50KEDWARDS LIFESCIENCES LLCProvide analysis and strategic advocacy support services to Edwards Lifesciences public policy priorities, including FDA regulatory and CMS coverage and reimbursement issue
- 2026-01-20$50KEDWARDS LIFESCIENCES LLCCoverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. Coverage with evidence development. 21st Century Cures 2.0
- 2026-01-20$50KEDWARDS LIFESCIENCES LLCMedicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Expiring healthcare extenders
- 2025-10-20$280KEDWARDS LIFESCIENCES LLCCorporate Tax Reform Proposals Tariffs Japan Reimbursement of Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R. 5343/S.1717) Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization/FDA User Fees Diversity in Clinical Trials CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R. 5343/S.1717) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development
- 2025-10-20$50KEDWARDS LIFESCIENCES LLCCoverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. Coverage with evidence development. 21st Century Cures 2.0
Congressional Momentum
buy vs. sell pressureACCUMULATINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
▲100
1 buy1 total0 sells
$8K buys · $0 sells
Last 90 Days
▲67
4 buys6 total2 sells
$32K buys · $16K sells
All-Time
▼34
13 buys28 total15 sells
$129K buys · $254K sells
Cumulative Net Position (buy vol − sell vol)
-$126K
2021-0328 trades plotted2026-05
Best Timers
avg excess return vs SPY · EW trades only6 members w/ alpha dataExcess return = stock price change minus SPY change over the same holding window.Congress avg: -19.3%· 0% of traders beat SPY on this name
Top Alpha Generators
D:2R:4House:6
underperformed SPY|beat SPY
Worst Timers
bottom 5 by avg excess return
underperformed SPY|beat SPY
Worst single trade: Mike Kelly (-48.2%)Best single trade: Ro Khanna (+6.1%)
Timing Fingerprint
filing delay vs. excess return over SPY · 19 tradesCongress avg -8.7% vs SPYEach dot = one disclosed trade. X-axis = days between trade and STOCK Act filing.Y-axis = return above (or below) SPY over the subsequent holding window. Upper-right = late filers who beat the market.
32% of trades beat SPYavg excess -8.7%avg delay 30d10 buys9 sellsBuySellOther· dot size ∝ trade size
Congress Swarm Events
synchronized trading — 3+ members within 21 daysMODERATEA swarm event occurs when 3 or more members disclose trades in EW within a rolling 21-day window. Tight windows with high directional consensus score highest on the suspicion meter.
🔴 #1MIXED3 members · 14d span
46
Window
2025-04-07 → 2025-04-21
▲ 2 buys▼ 2 sells$57K vol
Consensus
50%
RJefferson Shreve2025-04-07
RRobert Bresnahan2025-04-08
RBruce Westerman2025-04-212×
1 swarm event detectedmax members in single event: 3highest suspicion score: 4621-day rolling window · top 6 by score
Trade Activity Timeline
Congressional buys & sells by month · last 15 months w/ activity
21/03
23/04
23/06
24/04
24/08
24/11
25/03
25/04
25/05
25/10
25/11
26/02
26/03
26/04
26/05
BuysSellsOtherHigh-volume month
Who Moved First
each row = one member · sorted by earliest disclosed trade6 buyers ·6 sellers
BuySellOtherDot size ∝ trade size · top 8 most-active traders shown
Seasonal Rhythm
Congress buy/sell pressure by month & yearEach cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.
Net buyingNet sellingNo trades · number = trade count
Peak buy month: Mar · Peak sell month: Apr
Congressional Conviction Timeline
net positioning · alpha track recordMIXED13 buys15 sellscumulative α -60.3%15mo tracked
Monthly Net Flow (Buys − Sells)
Cumulative Excess Return on Congressional Buys vs SPY
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay | Receipt |
|---|---|---|---|---|---|
| 2026-05-27 | DRo Khanna | BUY | $1K – $15K | 13d | receipt → |
| 2026-05-15 | DRo Khanna | BUY | $1K – $15K | 25d | receipt → |
| 2026-05-01 | DRo Khanna | BUY | $1K – $15K | 39d | receipt → |
| 2026-04-24 | DRo Khanna | SELL | $1K – $15K | 17d | receipt → |
| 2026-04-13 | DRo Khanna | BUY | $1K – $15K | 28d | receipt → |
| 2026-03-30 | DRo Khanna | SELL | $1K – $15K | 8d | receipt → |
| 2026-03-23 | DRo Khanna | BUY | $1K – $15K | 15d | receipt → |
| 2026-02-05 | DRo Khanna | SELL | $1K – $15K | 32d | receipt → |
| 2025-11-19 | DJosh Gottheimer | SELL | $1K – $15K | 41d | receipt → |
| 2025-11-19 | DJosh Gottheimer | SELL | $1K – $15K | 40d | receipt → |
| 2025-11-19 | DJosh Gottheimer | SELL | $1K – $15K | 15d | receipt → |
| 2025-10-07 | DRo Khanna | SELL | $1K – $15K | 30d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $50K – $100K | 42d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $50K – $100K | 41d | receipt → |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 22d | receipt → |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 21d | receipt → |
| 2025-04-08 | RRobert Bresnahan | BUY | $1K – $15K | 30d | receipt → |
| 2025-04-07 | RJefferson Shreve | BUY | $15K – $50K | 31d | receipt → |
| 2025-03-03 | RBruce Westerman | BUY | $1K – $15K | 44d | receipt → |
| 2025-03-12 | DRo Khanna | BUY | $1K – $15K | 29d | receipt → |
| 2024-11-12 | DRo Khanna | BUY | $1K – $15K | 23d | receipt → |
| 2024-08-02 | DRo Khanna | SELL | $1K – $15K | 35d | receipt → |
| 2024-04-11 | RMike Kelly | SELL | $1K – $15K | 64d | receipt → |
| 2024-04-11 | RMike Kelly | SELL | $1K – $15K | 34d | receipt → |
| 2023-04-03 | RTommy Tuberville | SELL | $1K – $15K | 147d | receipt → |
| 2021-03-29 | RTommy Tuberville | BUY | $1K – $15K | 882d | receipt → |
| 2023-06-21 | RJohn Curtis | BUY | $1K – $15K | 26d | receipt → |
| 2023-04-26 | RJohn Curtis | BUY | $1K – $15K | 6d | receipt → |